(La Jolla, CA, March 11, 2007)
Human embryonic stem cells (hESCs) hold great promise for
benefiting degenerative diseases, and do so by invoking multiple
mechanisms. Such cells can be grown in a manner compatible with clinical
use (i.e., without animal feeder layers) and even without the need for
immunosuppression. These were a few of a number of conclusions arrived
at by an international collaboration led by Evan Y. Snyder, M.D., Ph.D.,
and spearheaded by a member of his lab, Jean-Pyo Lee, Ph.D., of the
Burnham Institute for Medical Research (”Burnham”). The study, to be
published in Nature Medicine, will be made available by advanced
publication at the journal’s website on March 11, 2007.
[more]